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SurvivalMethods: Patients diagnosed between 2010 and 2017 with International Federation of Gynae-
cology and Obstetrics (2009) stage IA2 with lymphovascular space invasion, IB1 and IIA1,
were identified from the Netherlands Cancer Registry. Cox regression with propensity score,
based on inverse probability treatment weighting, was applied to examine the effect of surgical
approach on 5-year survival and calculate hazard ratios (HR) and 95% confidence intervals
(CIs). Literature review included observational studies with (i) analysis on tumours 4 cm
(ii) median follow-up 30 months (iii) 5 events per predictor parameter in multivariable
analysis or a propensity score.
Results: Of the 1109 patients, LRH was performed in 33%. Higher mortality (9.4% vs. 4.6%)
and recurrence (13.1% vs. 7.3%) were observed in ARH than LRH. However, adjusted ana-
lyses showed similar DFS (89.4% vs. 90.2%), HR 0.92 [95% CI: 0.52e1.60]) and OS (95.2%
vs. 95.5%), HR 0.94 [95% CI: 0.43e2.04]). Analyses on tumour size (<2/2 cm) also gave
similar survival rates. Review of nine studies showed no distinct advantage of ARH, especially
in tumours <2 cm.
Conclusion: After adjustment, our retrospective study showed equal oncological outcomes be-
tween ARH and LRH for early-stage cervical cancer e also in tumours <2 cm. This is in cor-
respondence with results from our literature review.
ª 2020 Elsevier Ltd. All rights reserved.1. Introduction
Conventional and robot-assisted laparoscopic radical
hysterectomy (LRH) have been presented as alterna-
tives to abdominal radical hysterectomy (ARH) in
early-stage cervical cancer, in the previous decades. A
series of retrospective studies showed similar oncologic
outcomes [1e9]. In the absence of prospective rando-
mised studies, an international phase III non-
inferiority study (the Laparoscopic Approach to Cer-
vical Cancer (LACC) trial) was executed to determine
the safety of laparoscopic surgery in early-stage cervi-
cal cancer [10]. Unexpectedly, preliminary data showed
inferior disease-free survival (DFS) and recurrence
rates in patients treated by LRH, resulting in a pre-
mature termination of the trial [11]. Nearly simulta-
neously, a large observational study was published,
also demonstrating favourable overall survival (OS) in
ARH [12]. In addition, this study reported surgical
approach as independent prognostic factor for OS in
patients with a tumour 2 cm in diameter; it was
significantly lower in those treated by LRH. In tu-
mours <2 cm, no difference was detected between the
surgical approaches.
Since the LACC trial, numerous retrospective
observational studies have been published on oncolog-
ical outcomes comparing ARH and LRH in cervical
cancer. However, comparing observational study results
is difficult owing to diversities in disease-stage, follow-
up duration and statistical analysis.
The LACC trial results call into question the safety of
LRH in early-stage cervical cancer. Our aim was to
determine the effect of surgical approach on oncological
outcomes for cervical cancer patients in the
Netherlands. In addition, a literature review is provided,applying strict selection criteria for fair comparison of
observational studies.2. Materials and Methods
2.1. Study design
We performed a nationwide multicentre retrospective
cohort study by analysing data from the Netherlands
Cancer Registry (NCR), a population-based registry
with coverage of all newly diagnosed malignancies in the
Netherlands since 1989. Vital status and date of death
were obtained from the municipal demography
registries.
All women newly diagnosed with cervical cancer be-
tween 2010 and 2017 who underwent radical hysterec-
tomy with pelvic lymphadenectomy in one of the nine
specialised medical centres, were identified from the
NCR. We included patients with: International Feder-
ation of Gynaecology and Obstetrics (FIGO) 2009 stage
IA2 with lymphovascular space invasion (LVSI), IB1
and IIA1; adenocarcinoma, squamous cell carcinoma or
adenosquamous carcinoma; radical hysterectomy as
primary treatment. Patients were excluded if: neo-
adjuvant chemotherapy or (chemo)radiotherapy was
administered; previously diagnosed with cancer, except
non-melanoma skin cancer.
Data were collected on baseline characteristics and
disease-related characteristics (including follow-up time,
age at diagnosis, body mass index (BMI), use of diag-
nostic magnetic resonance imaging (MRI), clinical
tumour size, FIGO stage, surgical approach, histologi-
cal subtype, differentiation grade, pathological tumour
size, depth of invasion (DOI), LVSI, parametrial
involvement, resection margin involvement, number of
Fig. 1. Patient selection flowchart.
H.H.B. Wenzel et al. / European Journal of Cancer 133 (2020) 14e2116removed lymph nodes, number of positive lymph nodes,
adjuvant treatment, recurrence and all-cause mortality).
Surgical approach was categorised as ARH or LRH
(conventional or robot-assisted LRH), categorising
converted patients as LRH, in accordance with the
intention-to-treat principle. Recurrence was confirmed
preferably by pathological analysis (i.e. biopsy or
cytology), otherwise by radiological examination.
Literature review on oncological outcomes included
observational studies with analysis on tumours 4 cm
and a median follow-up 30 months, corresponding to
the LACC trial. In addition, at least 5 events per pre-
dictor parameter in multivariable analysis were required
to prevent model overfitting [13] or, alternatively, a
propensity score [14].
2.2. Ethics
This study was approved by the Privacy Review Board
of the NCR (11/12/2018; K18.377).
2.3. Statistical analysis
Differences between the ARH and LRH group were
assessed using Pearson’s chi-squared test, independent
samples t-test or Mann-Whitney U test. The primary
outcomes of this study were DFS and OS. Inverse
probability treatment weighting (IPTW) was applied to
examine the effect of surgical approach on recurrence
and all-cause mortality.
For the original model, for analyses on the full
cohort, covariates were selected based on their relation
with the outcome or possible confounding of the rela-
tion surgical approach with outcome, regardless of sig-
nificance. Age, BMI, year of diagnosis, FIGO-stage,
histological subtype, pathological tumour size, DOI,
LVSI, parametrial invasion and pathological lymph
nodes, were included. Missing values of pathological
tumour size were replaced by clinical tumour size
(reducing missing values from 15% to 4%). Weighted
Cox regression, on surgical approach with propensity
score as single covariate, was applied to calculate hazard
ratios (HRs) and 95% confidence intervals (CIs).
Sensitivity analyses were conducted to confirm the
robustness of our model. In the original model adjuvant
treatment was excluded because of the possibility of
being influenced by the radical hysterectomy [15]. To
determine whether differences in application of adjuvant
treatment between the ARH and LRH group have
confounded the association of surgical approach with
survival, the original model was adapted by adding
adjuvant treatment. In addition, in the original model,
differentiation grade was excluded due to a high rate of
missing values (28%). The original model was adapted
by adding differentiation grade. Furthermore, tradi-
tional multivariable Cox regression was executed with
replacement of the missing values from the originalmodel (i.e. BMI, parametrial invasion, LVSI, DOI and
pathological tumour size; missing 3%e15%), by multiple
imputation and without the application of IPTW.
We also conducted analyses on clinical tumour size
(<2 cm vs. 2 cm) as previous studies have reported
differences in survival between the surgical approaches
on this parameter. Likewise, to examine a possible
learning curve effect, we analysed the influence of period
of diagnosis on DFS in two separate models (2010e2013
vs. 2014e2016). Because of limited follow-up for the
2014e2016 group and the majority of recurrences
developing within two years after radical hysterectomy,
two-year DFS was calculated. Detailed information on
IPTW models of all analyses is presented in
Supplementary Materials Methods S1. All analyses were
performed using Stata/SE, version 14.2 (Stata Corpo-
ration, College Station, TX, USA). Statistical tests were
two-tailed and considered significant at p < 0.05.3. Results
A total of 1109 patients met the inclusion criteria
(Fig. 1) and were selected for this study. Baseline and
disease-related characteristics are presented in Table 1
and Table 2, respectively. We observed more patients
with large tumours (clinical diameter 2 cm; 59%) than
with small tumours (<2 cm; 41%). ARH was performed
in the majority of patients (67%). Of the LRH group
(33%), most patients were treated by robot (73%). In
2010e2013, 27% was treated by LRH and in 2014e2016
this increased to 34% (p Z 0.009).
Exploring postoperative differences between the
ARH and LRH groups, patients in the ARH group
more frequently had intermediate and high-risk factors
H.H.B. Wenzel et al. / European Journal of Cancer 133 (2020) 14e21 17for recurrence (Table 2) and tumours 2 cm (61% vs.
36%, p < 0.001). Correspondingly, patients in the ARH
group more often received adjuvant radiotherapy or
chemoradiation (28% vs. 15%, p < 0.001), Table 3.
Recurrence was seen more often in the ARH compared
with the LRH group (13% vs. 7%, p Z 0.004). Most of
the recurrences (n Z 76, 61%) occurred within two years
after radical hysterectomy.3.1. Survival analyses
Median follow-up duration for DFS and OS were 35
months (range: 0e100) and 56 months (range: 1e109),
respectively, with longer follow-up in the ARH group
(Table 1), p < 0.001. Eighty-seven patients (8%) have
died at time of analysis of which 70 (9%) underwent
ARH and 17 (5%) LRH, p Z 0.005. Survivor functions
of the primary outcomes are presented in Fig. 2, whereas
HRs and CIs for full cohort, sensitivity, and subgroup
analyses on survival are presented in Fig. 3.
Full cohort unadjusted analysis showed a lower 5-
year DFS (82.8% vs. 91.0%) and 5-year OS (91.1% vs.
95.2%) in ARH compared with LRH. After adjustment
by means of IPTW, weighted Cox regression analysis
showed DFS was 89.4% and 90.2% in the ARH and
LRH group, respectively (HR: 0.92; 95% CI:
[0.52e1.60]). OS was 95.2 and 95.5% in the ARH and
LRH group, respectively (0.94 [0.43e2.04]).3.2. Sensitivity analyses
Sensitivity analysis with adjustment for treatment and
differentiation grade, respectively, gave similar HRs and
95% CIs for DFS (0.92 [0.53e1.61] and 0.91
[0.51e1.60]) and OS (0.94 [0.43e2.04] and 0.98
[0.45e2.14). Replacing missing values by multipleTable 1
Baseline characteristics of 1109 patients with cervical cancer (FIGO stag
between 2010 and 2017 in the Netherlands.
Characteristics, n (%) Missing Full cohort (N Z 1109)
Age, years* 45 (11)
BMI, kg/m2* 32 (3) 25 (5)
Follow-up OS, monthsy 56 (1e109)
Follow-up DFS, monthsy 35 (0e100)
Use of diagnostic MRI 723 (65)
Clinical tumour size 181 (16)
<2 cm 384 (41)
2 cm 543 (59)
FIGO stage




y median (range).imputation, also provided similar results for DFS (0.88
[0.53e1.41]) and OS (0.88 [0.46e1.69]).
3.3. Clinical tumour size
Analysis on clinical tumours <2 cm showed 5-year DFS
was 91.4% and 96.0% in the ARH and LRH group,
respectively (0.44 [0.16e1.27]). Five-year OS was 96.4%
and 98.5% (0.39 [0.08e1.86]). In tumours 2 cm DFS
was 85.0% and 82.5% in the ARH and LRH group,
respectively (1.18 [0.64e2.21]). Five-year OS was 94.2%
and 92.8% (1.26 [0.53e2.99]).
3.4. Period of diagnosis
Analysis on patients diagnosed between 2010 and 2013
showed 2-year DFS was 95.8% and 91.7% in the ARH
and LRH group, respectively (2.01 [0.82e4.98]). Be-
tween 2014 and 2016 DFS was 90.3% and 94.7% in the
ARH and LRH group, respectively (0.53 [0.20e1.40]).
3.5. Literature review
Nine studies conducted at least one analysis meeting our
selection criteria for fair comparison of observational
studies (Table 4) [12,16e23]. Seven reported at least one
analysis with no significant association between surgical
approach and oncological outcome [17e23]. Four of
these found no difference in DFS between the surgical
approaches [17,18,21,23]. Three examined all-cause
mortality and observed no difference [17,22,23]. Jensen
et al. [19] examined DFS, OS and disease-specific sur-
vival before and after the introduction of robot radical
hysterectomy and reported no difference on any of the
outcomes.
Four studies reported significantly higher survival
rates in patients with ARH compared with LRHe IA2 with LVSI, IB1 and IIA1) treated with radical hysterectomy
ARH (n Z 740; 67%) LRH (n Z 369; 33%) P
46 (12) 44 (10) 0.003
25 (5) 25 (4) 0.380
60 (1e109) 46 (9e109) <0.001
37 (0e100) 29 (1e94) <0.001
450 (61) 273 (74) <0.001
<0.001
218 (34) 166 (56)
414 (66) 129 (44)
0.137
3 (0) 4 (1)
711 (96) 358 (97)
26 (4) 7 (2)
Table 2
Disease-related characteristics of abdominal and laparoscopic radical hysterectomy.
Characteristics, n (%) Missing Full cohort (N Z 1109) ARH (n Z 740; 67%) LRH (n Z 369; 33%) P
Histological subtype 0.711
Squamous cell carcinoma 738 (67) 490(66) 248 (67)
Adenocarcinoma 321 (29) 214 (29) 107 (29)
Adenosquamous carcinoma 50 (5) 36 (5) 14 (4)
Differentiation grade 311 (28) 0.147
1 90 (11) 57 (11) 33 (11)
2 408 (51) 242 (49) 166 (55)
3 300 (38) 198 (40) 102 (34)
Pathological Nþ, yes 165 (15) 135 (18) 30 (8) <0.001
Pathological tumour size 171 (15) <0.001
<2 cm 434 (46) 251 (39) 183 (64)
2e4 cm 425 (45) 329 (51) 96 (33)
>4 cm 79 (8) 71 (11) 8 (3)
Depth of invasion 62 (6) <0.001
5 mm 396 (38) 216 (31) 180 (51)
6e10 mm 387 (37) 262 (38) 125 (35)
>10 mm 264 (25) 216 (31) 48 (14)
Lymphovascular space invasion, yes 61 (6) 473 (45) 325 (47) 148 (41) 0.086
Parametrial involvement, yes 51 (5) 44 (4) 33 (5) 11 (3) 0.250
Surgical margin involvement, yes 45 (4) 33 (3) 28 (4) 5 (1) 0.031
Closest distance (mm)* 391 (35) 6.0 (4.4) 5.8 (4.2) 6.3 (4.7) 0.097
Recurrence, yes 124 (11) 97 (13) 27 (7) 0.004
Local 36 (29) 26 (27) 10 (37)
Regional 24 (19) 17 (18) 7 (26)
Distant 64 (52) 54 (56) 10 (37)
All-cause mortality 87 (8) 70 (9) 17 (5) 0.005




Characteristics, n (%) Full cohort (N Z 1109) ARH (n Z 740; 67%) LRH (n Z 369; 33%) P
Adjuvant treatment, yes 265 (24) 209 (28) 56 (15) <0.001
Chemoradiation 121 (11) 95 (13) 26 (7)
Radiotherapy 145 (13) 115 (16) 30 (8)
Adjuvant treatment, no 843 (76) 530 (72) 313 (85)
ARH, abdominal radical hysterectomy; LRH, laparoscopic radical hysterectomy.
H.H.B. Wenzel et al. / European Journal of Cancer 133 (2020) 14e2118[12,16,20,22]. Three studies [16,20,22] found significantly
higher DFS in ARH. Melamed et al. [12] conducted the
largest observational study to date and reported a
significantly higher OS. Interestingly, two studiesFig. 2. Cox regression survival functions, adjusted by inverse probab
LRH, laparoscopic radical hysterectomy.reported favourable DFS in ARH but observed no dif-
ference in OS [20,22]. Their analyses on all-cause mor-
tality were conducted with a low absolute number of
events (Paik et al. Z 7; Uppal et al. Z 13). Paik et al.ility treatment weighting. ARH, abdominal radical hysterectomy;
Fig. 3. Weighted Cox regression analyses with propensity score, based on inverse probability treatment weighting. DFS, disease-free
survival; OS, overall survival; HR, hazard ratio; CI, confidence interval.
H.H.B. Wenzel et al. / European Journal of Cancer 133 (2020) 14e21 19[20] expected the difference in OS to become statistically
significant with a larger sample size. Uppal et al. [22] did
not elaborate on the difference between their analysis on
recurrence and all-cause mortality. In our analyses, with
far more events, we neither found a difference in DFS
nor in OS. Moreover, this was confirmed in all sensi-
tivity analyses.
Four studies reported subanalyses on tumours
<2 cm [12,17,20,21]. None of these reported higher
OS in ARH. Three studies also examined DFS of
which two revealed no differences [17,21]. One study
conducted an analysis on a specially selected low-risk
subgroup and reported significantly lower DFS in
<2 cm tumours treated by LRH [20]. However, it
had a low absolute number of recurrences (Z7) andTable 4
Analyses from studies comparing abdominal and laparoscopic radical hy
multivariable Cox regression with 5 events per predictor parameter or a
Authors Year FIGO stage (2009) Treatment years N
Wallin et al. 2017 IA1eIB1, IIA1 2006e2015 304
Melamed et al.* 2018 IA2, IB1 2000e2018 246
Alfonzo et al.* 2019 IA1, IA2, IB1 2011e2017 464
Kim et al.* 2019 IB1 2000e2018 392
Paik et al.* 2019 IB1, IIA1 2000e2008 476
Brandt et al. 2020 IB1 2007e2017 145
Jensen et al. 2020 IA2, IB1 2005e2017 112
Pedone Anchora et al. 2020 IA1eIB1, IIA1 ? e 2016 423
Uppal et al.* 2020 IA1, IA2, IB1 2010e2017 315
OS, overall survival; DFS, disease-free survival; DSS, disease-specific surv
* Use of propensity score.a wide CI (1.45e116.24), thus evidently lacking
power. In a large Chinese study (N Z 1852), only
tumours 2 cm were examined but differences on
DFS were not observed [24]. In our study, we did
not detect significant differences in DFS and OS in
tumours <2 cm. Two studies reported subanalyses
on tumours 2 cm. Melamed et al. [12] reported
significantly lower OS in LRH. Pedone Anchora
et al. [21] reported lower DFS in LRH and similar
OS, but subgroup sample size was small (N Z 130).
We did not observe statistically significant differ-
ences, although our results tend to show worse
recurrence (HR: 1.18) and all-cause mortality (HR:
1.26) in LRH.sterectomy in tumours 4 cm, with 30 months follow-up and a
propensity score.
Recurrence (%) Survival analysis* P-value Preferred
surgical approach
12% 5-year DFS <0.05 ARH
1 e 4-year OS 0.002 ARH
12% 5-year DFS 0.756 None
5-year OS 0.990 None
10% 5-year DFS 0.100 None
5-year OS 0.300 None
7% e DFS 0.005 ARH
e OS 0.624 None
14% 5-year DFS 0.510 None
5 7% 5-year DFS 0.550 None
5-year DSS 0.100 None
5-year OS 0.100 None
17% e DFS >0.05 None
8% e DFS 0.019 ARH
e OS 0.400 None
ival; ARH, abdominal radical hysterectomy
H.H.B. Wenzel et al. / European Journal of Cancer 133 (2020) 14e21204. Discussion
We did not observe an effect of surgical approach on
DFS and OS in early-stage cervical cancer, in this
nationwide multicentre retrospective observational
study in the Netherlands. Besides, we did not find an
effect of clinical tumour size on the outcomes of ARH
vs. LRH.
Since the disclosure of the LACC trial results,
numerous studies have been published on oncological
outcomes comparing ARH and LRH in cervical cancer.
Our literature review, including nine retrospective
studies, showed no distinct advantage of ARH over
LRH in tumours 4 cm. An effect of surgical approach
on oncological outcome in tumours <2 cm was absent in
the majority of studies, suggesting the safety of the
application of LRH in this subgroup. In 2 tumours,
results seem to be in favour of ARH. The exact effect of
surgical approach on oncological outcomes in tumours
<2 vs. 2 cm requires further investigation in prospec-
tive randomised trials.
Recent literature suggests that the learning curve
might influence recurrence rates in LRH [25e27],
whereas other studies did not find such an effect
[12,17,28]. Our study focussed on 2010e2017, and this
time frame includes the introduction (which started in
2006) of the laparoscopic technique in several of the
centres. We observed an increase over time in survival in
LRH and a decrease in survival in ARH, although sta-
tistically insignificant. Learning curve might be one
possible explanation for differences between ARH and
LRH, but the present studies provide inconclusive
results.
Strengths of this large European study include: data
on recurrence and all-cause mortality, the application of
IPTW to balance distribution of covariates, a propensity
score to avoid overfitting issues and therefore making
treatment comparison more accurate [29], multiple
sensitivity analyses to confirm model robustness and the
introduction of strict selection criteria to increase
comparability of studies.
Although data from individual medical centres are
not presented in this article, the data suggest there are
differences in diagnostic work-up (for example in
determining clinical tumour size, or the use of MRI),
indications for ARH and LRH, the actual execution of
the radical hysterectomy (e.g. extent of parametrial
resection, nerve-sparing vs. non-nerve sparing, handling
preoperative suspected or intraoperative positive lymph
nodes and uterine manipulator use) and the criteria for
adjuvant (chemo)radiotherapy. Moreover, two centres
only perform ARH. In medical centres performing both
surgical approaches, high-risk patients might have been
selected for open surgery more often, possibly explain-
ing the patients in the ARH group were observed more
frequently with intermediate and high-risk factors forrecurrence. Pursuing uniformity on a national level will
result in more accurate comparisons. However, the
quantification of the required surgical parameters was
not within the scope of this research project. Further-
more, low numbers of events per centre prevented us
from in-depth analysis.
Observational research in general depends on the
quality of data in the medical record. As there are no
guidelines on reporting clinical tumour size and not all
medical centres use it as selection criterion for surgical
approach, there was a lack of uniformity in its definition
(i.e. based on MRI or clinical examination). However,
we do not expect this to have affected our results, as
conducting the analyses with pathological tumour size
instead, provided similar results. In addition, although
the IPTW technique was applied to make a fair com-
parison between ARH and LRH, unmeasured con-
founding cannot be adjusted for and all relevant
confounders might not have been included.
Our retrospective study showed equal oncological
outcomes between ARH and LRH for early-stage cer-
vical cancer, after IPTW adjustment. Moreover, we
observed no effect of surgical approach on DFS and OS
in tumours <2 cm. After a literature review on retro-
spective observational studies no distinct advantage of
ARH over LRH was found, especially in tumours
<2 cm. The exact role of LRH in the treatment of cer-
vical cancer should be examined in prospective rando-
mised trials.
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